142 related articles for article (PubMed ID: 34158188)
41. Acute localized exanthematous pustulosis caused by a herbal medicine, dai-kenchu-to.
Tsutsumi R; Yoshida Y; Adachi K; Nanba E; Yamamoto O
Contact Dermatitis; 2018 Oct; 79(4):257-259. PubMed ID: 30014493
[No Abstract] [Full Text] [Related]
42. Acute Localized Exanthematous Pustulosis Due to Alendronate.
Bautista-Villanueva S; Galleani C; Barranco R; Bellón T; Blanco M; García-Moguel I
J Investig Allergol Clin Immunol; 2021 Feb; 32(1):69-70. PubMed ID: 34045177
[No Abstract] [Full Text] [Related]
43. Haloperidol-Induced Acute Generalized Exanthematous Pustulosis: A Rare Side Effect.
Roy C; Jaiswal S; B P J; Paliwal S; Dey P; Mehta V
Prim Care Companion CNS Disord; 2022 Jun; 24(3):. PubMed ID: 35687886
[No Abstract] [Full Text] [Related]
44. Acute generalized exanthematous pustulosis induced by iodixanol (Visipaque): a serious reaction to a commonly used drug.
Ozturk U; Sungur MA; Karakas T; Mulayim K; Ozturk P
Cutan Ocul Toxicol; 2015; 34(4):344-6. PubMed ID: 25363067
[TBL] [Abstract][Full Text] [Related]
45. Acute Generalized Exanthematous Pustulosis Associated With a COVID-19 Infection.
Polat M; Parlakay AÖ
Pediatr Infect Dis J; 2022 Sep; 41(9):e406. PubMed ID: 35703310
[No Abstract] [Full Text] [Related]
46. Acute localised exanthematous pustulosis: Case report, review of the literature and proposed diagnostic criteria.
Ryder ENC; Perkins W
Australas J Dermatol; 2018 Aug; 59(3):226-227. PubMed ID: 28952145
[No Abstract] [Full Text] [Related]
47. Acute generalized exanthematous pustulosis due to hydroxichloroquine.
Odorici G; Schenetti C; Pacetti L; Schettini N; Gaban A; Mantovani L
Dermatol Ther; 2022 Jul; 35(7):e15520. PubMed ID: 35434875
[No Abstract] [Full Text] [Related]
48. COVID-19 vaccine-induced acute generalized exanthematous pustulosis.
Kang SY; Park SY; Kim JH; Lee SM; Lee SP
Korean J Intern Med; 2021 Nov; 36(6):1537-1538. PubMed ID: 34130372
[No Abstract] [Full Text] [Related]
49. Acute generalized exanthematous pustulosis induced by iron carboxymaltose infusion: A case report.
Bostan E; Yalcin HB; Akdogan N; Ozdemir DA; Karaduman A
Dermatol Ther; 2020 May; 33(3):e13445. PubMed ID: 32323452
[No Abstract] [Full Text] [Related]
50. Terbinafine-Induced Acute Generalized Exanthematous Pustulosis.
Correia B; Costa J; Egipto P; Reis P
J Burn Care Res; 2021 Aug; 42(4):829-831. PubMed ID: 33528556
[TBL] [Abstract][Full Text] [Related]
51. Acute generalized exanthematous pustulosis due to benznidazole.
Álava-Cruz C; Rojas Perez-Ezquerra P; Pelta-Fernández R; Zubeldia-Ortuño JM; de Barrio-Fernández M
J Allergy Clin Immunol Pract; 2014; 2(6):800-2. PubMed ID: 25439377
[No Abstract] [Full Text] [Related]
52. Hydroxychloroquine-induced acute generalized exanthematous pustulosis with positive patch-testing.
Charfi O; Kastalli S; Sahnoun R; Lakhoua G
Indian J Pharmacol; 2015; 47(6):693-4. PubMed ID: 26729969
[TBL] [Abstract][Full Text] [Related]
53. Acute Generalized Exanthematous Pustulosis Induced by the Second-Generation Antipsychotic Cariprazine.
Apgar RA; Dabiri G
Cutis; 2022 Jun; 109(6):E41-E42. PubMed ID: 35960962
[No Abstract] [Full Text] [Related]
54. A case report of a piperacillin/tazobactam-induced acute generalized exanthematous pustulosis.
Chousakos E; Rentziou G
Dermatol Ther; 2022 Aug; 35(8):e15650. PubMed ID: 35716092
[No Abstract] [Full Text] [Related]
55. June 2021: Acute generalized exanthematous pustulosis in Asia.
Kantor J
J Am Acad Dermatol; 2021 Jun; 84(6):1544. PubMed ID: 33892969
[No Abstract] [Full Text] [Related]
56. Is neutrophilic desquamative erythroderma a form of acute generalized exanthematous pustulosis?
Weins AB; Scharffetter-Kochanek K; Weiss T; Brockow K; Biedermann T; Psotta-Schachtner C; Mockenhaupt M; Weiss JM
J Eur Acad Dermatol Venereol; 2018 Jun; 32(6):e230-e232. PubMed ID: 29224230
[No Abstract] [Full Text] [Related]
57. Acute generalized exanthematous pustulosis induced by terbinafine in a child confirmed by patch testing.
Zaouak A; Ben Salem F; Charfi O; Hammami H; Fenniche S
Int J Dermatol; 2019 Feb; 58(2):e42-e43. PubMed ID: 30255495
[No Abstract] [Full Text] [Related]
58. [CD30 lymphocytic infiltrate and acute generalized exanthematous pustulosis].
Brault F; Antunes L; Valois A; Brouillard C; Assie C; Waton J; Cuny JF
Ann Dermatol Venereol; 2017 Oct; 144(10):634-636. PubMed ID: 28454728
[No Abstract] [Full Text] [Related]
59. Acute generalized exanthematous pustulosis: a case series of 13 patients in Brazil.
Costa DAM; Seque CA; Enokihara MMSS; Porro AM
J Eur Acad Dermatol Venereol; 2019 Feb; 33(2):e52-e55. PubMed ID: 29992639
[No Abstract] [Full Text] [Related]
60. Acute generalized exanthematous pustulosis associated with ranolazine.
Grelck K; Stewart N; Rosen L; Sukal S
Cutis; 2015 Oct; 96(4):E18-21. PubMed ID: 26682297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
